{"id":50926,"date":"2022-11-16T09:02:06","date_gmt":"2022-11-16T08:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/"},"modified":"2022-11-16T09:02:06","modified_gmt":"2022-11-16T08:02:06","slug":"labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/","title":{"rendered":"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer"},"content":{"rendered":"
\n

\nRahko\u2019s Co-founder and former VP of AI at Odyssey Therapeutics will lead the technical growth of LabGenius\u2019 ML-driven drug discovery platform\n<\/p>\n

LONDON–(BUSINESS WIRE)–#AI<\/a>–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced the appointment of Leonard Wossnig Ph.D. as Chief Technology Officer (CTO). In this role, Leonard will lead a team of Data Scientists, Software Engineers, and Automation Experts to further enhance LabGenius\u2019 data-driven platform capabilities.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cLeonard is a brilliant addition to our team,\u201d <\/i>says LabGenius\u2019 CEO and Founder, Dr. James Field. \u201cHis proven track record of implementing cutting-edge machine learning solutions for drug discovery programmes will supercharge our ability to deliver across multiple discovery projects.\u201d<\/i>\n<\/p>\n

\nIn 2018, Leonard co-founded Rahko, a leading quantum machine learning company whose technology platform combined computational chemistry, machine learning and quantum computing to drive a better understanding of drug behaviour. During his time as CEO, Leonard directed Rahko\u2019s commercial and scientific strategy, which aimed to remove bottlenecks in drug discovery by applying quantum machine learning models to the identification and optimisation of potential drug candidates. Earlier this year, Rahko was acquired by Odyssey Therapeutics, where, as VP of AI, Leonard led a team of machine learning experts to develop a computational platform for generative drug design in the areas of cancer and inflammation.\n<\/p>\n

\nCommenting on his appointment, Leonard said: \u201cThe ML-driven antibody-based platform that the team at LabGenius has built presents an opportunity to revolutionise today\u2019s approach to drug discovery. Through the development of bespoke automated pipelines, the team is able to generate high-quality data at scale \u2014 this is a crucial precursor to the effective use of machine learning. With these solid foundations in place, I am excited to apply my experiences to help unlock the vast potential that computational methods have to accelerate the discovery of better medicines.\u201d<\/i>\n<\/p>\n

\nDr. Edwin Moses, LabGenius\u2019 Chairman commented that \u201cLeonard’s appointment reinforces LabGenius\u2019 commitment to technical excellence. His expertise in generative molecule design, paired with LabGenius\u2019 cutting-edge drug discovery platform, is an excellent combination, which will further accelerate the company\u2019s ability to discover uniquely powerful protein-based therapeutics.\u201d<\/i>\n<\/p>\n

\n\u2013 end \u2013<\/b>\n<\/p>\n

\nAbout LabGenius
\n
<\/b>Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company\u2019s core technology platform, EVA\u2122<\/i><\/b>, enables the rapid discovery of novel therapeutic antibodies. LabGenius\u2019 highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.\n<\/p>\n

\nFor more information, please visit www.labgeni.us<\/a>, or connect on Twitter<\/a>, LinkedIn<\/a> and Medium<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor media enquiries, please contact Lucy Shaw at press@labgeni.us<\/a>
For business development, please contact James Field at partnerships@labgeni.us<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Rahko\u2019s Co-founder and former VP of AI at Odyssey Therapeutics will lead the technical growth of LabGenius\u2019 ML-driven drug discovery platform LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced the appointment of Leonard Wossnig Ph.D. as Chief Technology Officer (CTO). In this role, Leonard will lead … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50926","6":"format-standard","7":"category-industry"},"yoast_head":"\nLabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Rahko\u2019s Co-founder and former VP of AI at Odyssey Therapeutics will lead the technical growth of LabGenius\u2019 ML-driven drug discovery platform LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced the appointment of Leonard Wossnig Ph.D. as Chief Technology Officer (CTO). In this role, Leonard will lead ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T08:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221115005063\/en\/1634151\/21\/Leonard_headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer\",\"datePublished\":\"2022-11-16T08:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/\"},\"wordCount\":452,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005063\\\/en\\\/1634151\\\/21\\\/Leonard_headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/\",\"name\":\"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005063\\\/en\\\/1634151\\\/21\\\/Leonard_headshot.jpg\",\"datePublished\":\"2022-11-16T08:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005063\\\/en\\\/1634151\\\/21\\\/Leonard_headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005063\\\/en\\\/1634151\\\/21\\\/Leonard_headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/","og_locale":"en_US","og_type":"article","og_title":"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer - Pharma Trend","og_description":"Rahko\u2019s Co-founder and former VP of AI at Odyssey Therapeutics will lead the technical growth of LabGenius\u2019 ML-driven drug discovery platform LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced the appointment of Leonard Wossnig Ph.D. as Chief Technology Officer (CTO). In this role, Leonard will lead ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T08:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221115005063\/en\/1634151\/21\/Leonard_headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer","datePublished":"2022-11-16T08:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/"},"wordCount":452,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115005063\/en\/1634151\/21\/Leonard_headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/","url":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/","name":"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115005063\/en\/1634151\/21\/Leonard_headshot.jpg","datePublished":"2022-11-16T08:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221115005063\/en\/1634151\/21\/Leonard_headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221115005063\/en\/1634151\/21\/Leonard_headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/labgenius-appoints-dr-leonard-wossnig-as-chief-technology-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50926"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50926\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}